BIRC5 and ovarian serous cystadenocarcinoma: In a study of FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma, the activation of the PI3K/AKT pathway mediated the upregulated expression of survivin and then promoted VEGF expression [34].